Microneedle Patch Study in Healthy Infants/Young Children

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

July 11, 2017

Primary Completion Date

May 15, 2019

Study Completion Date

May 15, 2019

Conditions
VaccinationSkin Absorption
Interventions
DEVICE

Microneedle Formulation 1

"Microneedle patches will be made of solid conical structures made of water-soluble excipients that from the Food and Drug Administration's Generally Recognized as Safe (GRAS) list and/or on the FDA list of inactive ingredients in approved products. The total mass of excipients delivered by placebo microneedle patch will be \<1.5 mg. The adhesive backing component is made from hypoallergenic material (commercial medical tapes designed to adhere to skin).~Microneedle patches will be administered topically by manual application to the skin. The sites of microneedle patch application will be cleaned with an alcohol swab and allowed to dry before the microneedle patch is applied. The microneedle patches will be packaged and provided as single patches."

DEVICE

Microneedle Formulation 2

"Microneedle patches will be made of solid conical structures made of water-soluble excipients that from the Food and Drug Administration's Generally Recognized as Safe (GRAS) list and/or on the FDA list of inactive ingredients in approved products. The ratio of the excipients and excipients used will vary slightly from Formulation 1. The total mass of excipients delivered by placebo microneedle patch will be \<1.5 mg. The adhesive backing component is made from hypoallergenic material (commercial medical tapes designed to adhere to skin).~Microneedle patches will be administered topically by manual application to the skin. The sites of microneedle patch application will be cleaned with an alcohol swab and allowed to dry before the microneedle patch is applied. The microneedle patches will be packaged and provided as single patches."

Trial Locations (1)

30322

Emory Children's Center, Atlanta

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Micron Biomedical, Inc

INDUSTRY

lead

Emory University

OTHER

NCT03207763 - Microneedle Patch Study in Healthy Infants/Young Children | Biotech Hunter | Biotech Hunter